{"disease":{"id":"avatrombopag","name":"avatrombopag"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05218226","title":"Avatrombopag for Chemotherapy-induced Thrombocytopenia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04896528","title":"Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}